Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 184.15
+4.30 (2.39%)
May 11, 2026, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 238.81 billion as of May 11, 2026. Its market cap has decreased by -18.27% in one year.
Market Cap
238.81B
Enterprise Value
282.01B
Revenue
88.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
184.15
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 238.81B, an increase of 5.33%. That is a compound annual growth rate of 1.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 238.81B | 4.44% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 393.90B |
| Ajanta Pharma | 379.03B |
| Gland Pharma | 313.76B |
| Emcure Pharmaceuticals | 311.50B |
| Wockhardt | 261.04B |
| NATCO Pharma | 210.40B |
| Eris Lifesciences | 192.03B |
| Cohance Lifesciences | 186.77B |